ANXA1 and serum lipopolysaccharide activity: On one hand AnxA1 or peptide Ac2-26 treatment, in the case of LPS-induced endotoxemia, inhibited TNF-α release [31,32], whereas in the absence of AnxA1, increased levels of the cytokine was observed [23].